Business Context and Reporting Period
Company: OptimizeRx Corporation (OPRX)
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2025
Reporting Period: Fourth quarter and full year ended December 31, 2024
This filing serves as a notification that the company issued a press release on March 12, 2025, announcing financial results for the period ended December 31, 2024, along with Key Performance Indicators (KPIs) and initial guidance for 2025. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is furnished, not filed, for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical values for the following metrics. The filing states that these details are located in the attached press release (Exhibit 99.1):
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
- Key Performance Indicators: Mentioned as included in the press release, but values are not listed here.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior comparable period. It only confirms that results for the fourth quarter and full year 2024 were announced.
Guidance, Outlook, and Risks
- Guidance: The company provided initial guidance for the year 2025 in the press release referenced in this filing.
- Management Commentary: Specific commentary is contained within Exhibit 99.1 and is not detailed in the 8-K cover text.
- Risks and Contingencies: No specific risks or contingencies are detailed in this text segment.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 12, 2025) for actual revenue, profit, and cash flow figures.
- Verify the specific 2025 guidance targets mentioned in the press release.
- Check the Key Performance Indicators disclosed in the press release to assess operational health.
- Confirm the status of the company's liquidity and debt positions as detailed in the full financial results.